1. White-Dzuro, G, Gibson, LE, Zazzeron, L, et al. Multisystem effects of COVID-19: a concise review for practitioners. Postgrad Med. 2021;133(1):20-27. doi:10.1080/00325481.2020.1823094.
Google Scholar | Crossref | Medline2. Kothandaraman, N, Rengaraj, A, Xue, B, et al. COVID-19 endocrinopathy with hindsight from SARS. Am J Physiol Endocrinol Metab. 2021;320:E139-E150. doi:10.1152/ajpendo.00480.2020.
Google Scholar | Crossref | Medline3. Lundholm, MD, Poku, C, Emanuele, N, Emanuele, MA, Lopez, N. SARS-CoV-2 (COVID-19) and the endocrine system. J Endocr Soc. 2020;4. doi:10.1210/jendso/bvaa144.
Google Scholar | Crossref | Medline4. Pal, R, Banerjee, M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest. 2020;43:1027-1031. doi:10.1007/s40618-020.
Google Scholar | Crossref | Medline5. Scappaticcio, L, Pitoia, F, Esposito, K, Piccardo, A, Trimboli, P. Impact of COVID-19 on the thyroid gland: an update. Rev Endocr Metab Disord. 2020;1-13. doi:10.1007/s11154-020.
Google Scholar | Crossref | Medline6. Chakraborty, U, Ghosh, S, Chandra, A, Ray, AK. Subacute thyroiditis as a presenting manifestation of COVID-19: a report of an exceedingly rare clinical entity. BMJ Case Rep. 2020;13:e239953. doi:10.1136/bcr-2020.
Google Scholar | Crossref7. Khatri, A, Charlap, E, Kim, A. Subacute thyroiditis from COVID-19 infection: a case report and review of literature. European Thyroid Journal. 2020;9:324-328. doi:10.1159/000511872.
Google Scholar | Crossref | Medline8. Mehmood, MA, Bapna, M, Arshad, M. A case of post-COVID-19 subacute thyroiditis. Cureus. 2020;12:e12301. doi:10.7759/cureus.12301.
Google Scholar | Crossref9. Lania, A, Sandri, MT, Cellini, M, Mirani, M, Lavezzi, E, Mazziotti, G. Thyrotoxicosis in patients with COVID-19: the THYRCOV study. Eur J Endocrinol. 2020;183(4):381-387. doi:10.1530/eje-20.
Google Scholar | Crossref | Medline10. Jiménez-Blanco, S, Pla-Peris, B, Marazuela, M. COVID-19: a cause of recurrent Graves’ hyperthyroidism? J Endocrinol Invest. 2021;44(2):387-388. doi:10.1007/s40618-020.
Google Scholar | Crossref | Medline11. Mateu-Salat, M, Urgell, E, Chico, A. SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves’ disease after COVID-19. J Endocrinol Invest. 2020;43(10):1527-1528. doi:10.1007/s40618-020.
Google Scholar | Crossref | Medline12. Harris, A, Al Mushref, M. Graves’ thyrotoxicosis following SARS-CoV-2 infection. AACE Clin Case Rep. 2021;7(1):14-16. doi:10.1016/j.aace.2020.12.005.
Google Scholar | Crossref | Medline13. Rockett, J, Nelson, C, Pierce, R, Van Morlan, A. A case report of Graves’ disease following SARS-CoV-2 infection. Int J Contemp Pediatr. 2021;8:1260. doi:10.18203/2349-3291.ijcp20212481.
Google Scholar | Crossref14. Bayar, I, Tahri, S, Hajji, E, et al. A case of Grave’s disease following SARS-Cov 2 infection. Endocrine Abstracts. 2021; 73: AEP657. doi:10.1530/endoabs.73.AEP657.
Google Scholar15. Ly, A, Neutel, B., Goodman, E. A perfect storm: a case of thyrotoxicosis in the setting of COVID-19 infection and methamphetamine use. Proceedings of UCLA Health. 2021;25. https://proceedings.med.ucla.edu/index.php/2021/08/04/a-perfect-storm-a-case-of-thyrotoxicosis-in-the-setting-of-covid-19-infection-and-methamphetamine-use/. Accessed November 2, 2021.
Google Scholar16. Pastor, S, Molina, Á, De Celis, E. Thyrotoxic crisis and COVID-19 infection: an extraordinary case and literature review. Cureus. 2020;12:e11305-e11305. doi:10.7759/cureus.11305.
Google Scholar | Crossref | Medline17. Burch, HB, Wartofsky, L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am. 1993;22:263-277.
Google Scholar | Crossref | Medline | ISI18. Liu, Y, Sawalha, AH, Lu, Q. COVID-19 and autoimmune diseases. Current Opinion in Rheumatology. 2021;33:155.
Google Scholar | Crossref | Medline19. Kanduc, D, Shoenfeld, Y. Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine. Immunol Res. 2020;68(5):310-313. doi:10.1007/s12026-020.
Google Scholar | Crossref | Medline20. Smith, TJ, Hegedüs, L. Graves’ disease. New Engl J Med. 2016;375:1552-1565. doi:10.1056/nejmra1510030.
Google Scholar | Crossref | Medline21. Vera-Lastra, O, Ordinola Navarro, A, Cruz Domiguez, MP, Medina, G, Sánchez Valadez, TI, Jara, LJ. Two cases of Graves’ disease following SARS-CoV-2 vaccination: an autoimmune/inflammatory syndrome induced by adjuvants. Thyroid. 2021;31(9):1436-1439.
Google Scholar | Crossref | Medline22. Franquemont, S, Galvez, J. Subacute thyroiditis after mRNA vaccine for Covid-19. J Endocr Soc. 2021;5:A956-A957. doi:10.1210/jendso/bvab048.1954.
Google Scholar | Crossref23. Polack, FP, Thomas, SJ, Kitchin, N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New Engl J Med. 2020;383:2603-2615. doi:10.1056/NEJMoa2034577.
Google Scholar | Crossref | Medline